Literature DB >> 32024370

Analytical Methods for Determination of Apremilast from Bulk, Dosage Form and Biological Fluids: A Critical Review.

Pooja Kulkarni1, Ashwini Deshpande1.   

Abstract

Apremilast is an anti-inflammatory agent. It has been a flourishing molecule in the field of dermatology. In the year 2014, Apremilast got its approval for treatment of psoriatic arthritis. Presently it is known to treat a number of other conditions, including atopic dermatitis and plaque psoriasis. Apremilast a phthalimide derivative, is non-hygroscopic in nature. It is practically insoluble in water. Apremilast acts by inhibiting the activity of phosphodiesterase 4 (PDE4), an intracellular enzyme. Analytical method plays a key role to understand the physio-chemical properties of a drug molecule. Because of poor solubility and low permeability, analytical method development and formulation becomes challenging. Till date, there are no standard test methods available to analyze Apremilast. So, a critical review of the analytical techniques of Apremilast was carried out. The literature search was done by screening the papers reporting analytical techniques of Apremilast from year 2014 to 2019. Methodologies particularly UV spectroscopy, HPTLC, HPLC, X-ray diffraction, NMR, LC-MS were collected and reviewed. Interminable efforts are made by the researchers to develop simple, accurate, robust and cost-effective methods of analysis. In pharmaceutical research, this information will aid in the development of new delivery systems. The review will prove beneficial and advantageous pre-formulation studies and will guide the formulation development.

Entities:  

Keywords:  Analytical methods; Apremilast; HPLC; formulation

Year:  2020        PMID: 32024370     DOI: 10.1080/10408347.2020.1718481

Source DB:  PubMed          Journal:  Crit Rev Anal Chem        ISSN: 1040-8347            Impact factor:   6.535


  4 in total

1.  Effect of Penetration Enhancers and Safety on the Transdermal Delivery of Apremilast in Skin.

Authors:  Paulo Sarango-Granda; Lupe Carolina Espinoza; Natalia Díaz-Garrido; Helen Alvarado; María J Rodríguez-Lagunas; Laura Baldomá; Ana Calpena
Journal:  Pharmaceutics       Date:  2022-05-07       Impact factor: 6.525

2.  COVID-19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast.

Authors:  A Pacifico; A d'Arino; P D M Pigatto; P Malagoli; G Damiani
Journal:  Clin Exp Dermatol       Date:  2021-06-09       Impact factor: 4.481

3.  Apremilast Microemulsion as Topical Therapy for Local Inflammation: Design, Characterization and Efficacy Evaluation.

Authors:  Paulo Sarango-Granda; Marcelle Silva-Abreu; Ana Cristina Calpena; Lyda Halbaut; María-José Fábrega; María J Rodríguez-Lagunas; Natalia Díaz-Garrido; Josefa Badia; Lupe Carolina Espinoza
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-21

4.  Quantitation of Apremilast in Beagle Dogs Plasma by UPLC-MS-MS and Its Application to Pharmacokinetic Studies.

Authors:  Wei Xiong; Ling Wang; Haiyan Zhang; Xiaoqiu Tao; Xuehua Jiang; Zejuan Liu; Jiajia Zhao; Wenwen Xu
Journal:  J Anal Methods Chem       Date:  2021-01-15       Impact factor: 2.193

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.